4:08 PM ET
8-K
Contract Win
Emergent BioSolutions Wins $22.3M Contract from U.S. Department of War
Emergent BioSolutions received a $22.3 million modification exercising an option under an existing IDIQ contract to supply BioThrax (Anthrax Vaccine Adsorbed) to the U.S. Department of War. Deliveries will begin in 2026 with a $7.4 million initial shipment and continue through 2027 to support anthrax pre-exposure prophylaxis for all branches of the U.S. military.
- Value
- $22.3M
- Counterparty
- U.S. Department of War
- Term
- through 2027